He is the co-founder and chief scientific officer of Navigenics. BD
Gene tests one day will be as common as blood-pressure checks or cholesterol screens as tools that doctors use to help people fend off serious disease. At least that's the vision of scientists such as Dietrich Stephan. Stephan, who has served as the Translational Genomics Research Institute's deputy director for discovery research and director of the neurogenomics division over the past five years, will leave the Arizona research group for his own company, a San Francisco Bay Area consumer genomics firm called Navigenics.
0 comments :
Post a Comment